| Chasse Margot Bailey-dorton, MD | |
|
1021 Morehead Medical Dr, Ste A, Charlotte, NC 28204-2990 | |
| (980) 442-2000 | |
| Not Available |
| Full Name | Chasse Margot Bailey-dorton |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 1021 Morehead Medical Dr, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326099193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9401124 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Charlotte-mecklenburg Hospital Authority | 2961310685 | 488 |
| The Charlotte-mecklenburg Hospital Authority | 2961310685 | 488 |
News Archive
Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.
Many countries are now in lockdown in an attempt to contain the spread of the novel coronavirus, now called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus has sickened 2.47 million people worldwide, triggering many preventive measures. Now, it appears that preventive measures taken in Australia are containing the virus, according to a new modeling.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.
Many countries are now in lockdown in an attempt to contain the spread of the novel coronavirus, now called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus has sickened 2.47 million people worldwide, triggering many preventive measures. Now, it appears that preventive measures taken in Australia are containing the virus, according to a new modeling.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.
Many countries are now in lockdown in an attempt to contain the spread of the novel coronavirus, now called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus has sickened 2.47 million people worldwide, triggering many preventive measures. Now, it appears that preventive measures taken in Australia are containing the virus, according to a new modeling.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chasse Margot Bailey-dorton, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Chasse Margot Bailey-dorton, MD 1021 Morehead Medical Dr, Ste A, Charlotte, NC 28204-2990 Ph: (980) 442-2000 |
News Archive
Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.
Many countries are now in lockdown in an attempt to contain the spread of the novel coronavirus, now called the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus has sickened 2.47 million people worldwide, triggering many preventive measures. Now, it appears that preventive measures taken in Australia are containing the virus, according to a new modeling.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
Lillian M. Teigland, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6324 Fairview Rd, Suite 201, Charlotte, NC 28210 Phone: 704-384-0588 Fax: 704-384-0580 | |
Felice A James, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 251 Eastway Dr, Charlotte, NC 28213 Phone: 704-446-9991 | |
Heather M. Burney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Rozzelles Ferry Rd, Charlotte, NC 28208 Phone: 704-446-9987 | |
Dr. Jerome Howard, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6111 Rumple Rd, Charlotte, NC 28262 Phone: 704-596-5067 Fax: 704-599-9458 | |
Vishalakshi Kalyana Sundaram, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Vail Ave, Ste 400, Charlotte, NC 28207 Phone: 704-304-7000 | |
Thamrah Rhoxana Wright, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1918 Randolph Rd Ste 275, Charlotte, NC 28207 Phone: 704-384-1354 | |
Dr. Carlos B Jorge, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 309 S Sharon Amity Rd Ste 206, Charlotte, NC 28211 Phone: 704-360-5018 Fax: 980-273-1102 |